Utah Medical Products, Inc. (Nasdaq:UTMD) has reported corrected results for its tender offer, which expired Tuesday October 27. The company said 327,740 shares were purchased for $24,580,500.
The offer, launched on September 24, sought to acquire up to 650,000 shares of Utah Medical Products’ common stock at $75.00 per share.
The company reported an effective cost of 75.35/ share. At the reported date, 2,849,041 shares remained outstanding, including 1,775 employee option shares exercised in October.
Utah Medical Products said $107,720 in administration fees will be paid to the depositary and information agent. The company also reported $6,732 in filing fees payable to the SEC.
In addition, another 1% excise tax will be levied by the federal government on share repurchases.
Utah Medical Products develops, manufactures and markets disposable and reusable specialty medical devices. The company has a particular interest in health care for women and their babies, and said its products are recognised by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients.
Utah Medical Products, Inc. reported that its tender offer purchased 327,740 shares for $24,580,500. The issuer had offered to purchase up to 650,000 shares of its common stock.
Utah Medical Products, Inc. announced the corrected results on October 29, 2026.
Utah Medical Products, Inc.'s tender offer expired Tuesday October 27.
Utah Medical Products, Inc. offered to purchase its common stock at $75.00 per share.
Utah Medical Products, Inc. purchased 327,740 shares through the tender offer.
Utah Medical Products, Inc. reported that remaining shares outstanding at this date were 2,849,041, including 1,775 employee option shares exercised in October.
Utah Medical Products, Inc. reported that the effective cost of the tender offer was 75.35/ share.
Utah Medical Products, Inc. said that $107,720 in administration fees will be paid to the depositary and information agent, along with $6,732 in filing fees to the SEC. Another 1% excise tax will be levied by the federal government on share repurchases.
Utah Medical Products, Inc.'s shares are listed on Nasdaq under the ticker symbol UTMD.
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices, with particular interest in health care for women and their babies. The company says its products are recognised by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients.